GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹590 Cr | ₹611 Cr | ₹1,695 Cr | ₹358 Cr | ₹93 Cr |
What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹590 Cr |
| Mar2024 | ₹611 Cr |
| Mar2023 | ₹1,695 Cr |
| Mar2022 | ₹358 Cr |
| Mar2021 | ₹93 Cr |
How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹590 Cr | -3.39 | |
| Mar2024 | ₹611 Cr | -63.97 | |
| Mar2023 | ₹1,695 Cr | 373.19 | |
| Mar2022 | ₹358 Cr | 284.26 | |
| Mar2021 | ₹93 Cr | - | |
Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹38,270.8 Cr | -5.1% | -13.8% | -21.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -5.1% |
-13.8% |
-21.1% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses